For: | Wu ZF, Wu XY, Zhu N, Xu Z, Li WS, Zhang HB, Yang N, Yao XQ, Liu FK, Yang GS. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma. World J Gastroenterol 2015; 21(3): 935-943 [PMID: 25624728 DOI: 10.3748/wjg.v21.i3.935] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i3/935.htm |
Number | Citing Articles |
1 |
Nicolás Goldaracena, Andre Gorgen, Gonzalo Sapisochin. Current status of liver transplantation for cholangiocarcinoma. Liver Transplantation 2018; 24(2): 294 doi: 10.1002/lt.24955
|
2 |
Kai Zhang, Jie Yu, Xiaoling Yu, Zhiyu Han, Zhigang Cheng, Fangyi Liu, Ping Liang. Clinical and survival outcomes of percutaneous microwave ablation for intrahepatic cholangiocarcinoma. International Journal of Hyperthermia 2018; 34(3): 292 doi: 10.1080/02656736.2017.1327678
|
3 |
Guojun Qian, Jinglei Zhang, Feng Shen. Intrahepatic Cholangiocarcinoma. 2019; : 123 doi: 10.1007/978-3-030-22258-1_9
|
4 |
Xia Sheng, Jian-Min Qin. Mechanism of postoperative recurrence and metastasis of intrahepatic cholangiocellular carcinoma and clinical prevention and treatment strategy. World Chinese Journal of Digestology 2023; 31(18): 753 doi: 10.11569/wcjd.v31.i18.753
|
5 |
PO ZHAO, XIAOYING LI, YALI LU, LIN LIU. Downregulated expression of PHLDA1 protein is associated with a malignant phenotype of cholangiocarcinoma. Oncology Letters 2015; 10(2): 895 doi: 10.3892/ol.2015.3316
|
6 |
Seogsong Jeong, Ying Tong, Meng Sha, Jinyang Gu, Qiang Xia. Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Oncotarget 2017; 8(10): 17292 doi: 10.18632/oncotarget.14079
|
7 |
R. Connor Chick, Samantha M. Ruff, Timothy M. Pawlik. Factors associated with prognosis and staging of intrahepatic cholangiocarcinoma. Journal of Cancer Metastasis and Treatment 2024; doi: 10.20517/2394-4722.2024.47
|
8 |
Seogsong Jeong, Qingbao Cheng, Lifeng Huang, Jian Wang, Meng Sha, Ying Tong, Lei Xia, Longzhi Han, Zhifeng Xi, Jianjun Zhang, Xiaoni Kong, Jinyang Gu, Qiang Xia. Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3464-5
|
9 |
You-Yin Tang, Yu-Nuo Zhao, Tao Zhang, Zhe-Yu Chen, Xue-Lei Ma. Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma. World Journal of Gastroenterology 2021; 27(41): 7173-7189 doi: 10.3748/wjg.v27.i41.7173
|
10 |
Seogsong Jeong, Lei Gao, Ying Tong, Lei Xia, Ning Xu, Meng Sha, Jianjun Zhang, Xiaoni Kong, Jinyang Gu, Qiang Xia. Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection. Canadian Journal of Gastroenterology and Hepatology 2017; 2017: 1 doi: 10.1155/2017/6543423
|
11 |
Rui Zhou, Dihan Lu, Wenda Li, Wenliang Tan, Sicong Zhu, Xianqing Chen, Jun Min, Changzhen Shang, Yajin Chen. Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis. HPB 2019; 21(7): 784 doi: 10.1016/j.hpb.2018.12.011
|
12 |
Dong‐Hwan Jung, Shin Hwang, Ki‐Hun Kim, Seung‐Mo Hong, Young‐Joo Lee, Chul‐Soo Ahn, Deok‐Bog Moon, Tae‐Yong Ha, Gi‐Won Song, Gil‐Chun Park, Eun Sil Yu, Sung‐Gyu Lee. Clinicopathological Features and Post‐resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. World Journal of Surgery 2017; 41(3): 825 doi: 10.1007/s00268-016-3787-4
|
13 |
Jun Fu, Qinjunjie Chen, Yuyan Yu, Wuyi You, Zongren Ding, Yuzhen Gao, Haitao Li, Yongyi Zeng. Impact of portal hypertension on short‐ and long‐term outcomes after liver resection for intrahepatic cholangiocarcinoma: A propensity score matching analysis. Cancer Medicine 2021; 10(20): 6985 doi: 10.1002/cam4.4222
|
14 |
Feiyu Li, Yong Jiang, Liyong Jiang, Qingbin Li, Xiangyu Yan, Songhan Huang, Ji Chen, Shuai Yuan, Yingda Fu, Jun Liu. Effect of lymph node resection on prognosis of resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.957792
|
15 |
Zeyuan Qiang, Kunfu Dai, Yuting He, Zhenwei Yang, Lianyuan Tao, Huifeng Zhang, Haibo Yu. The prognostic value of stromal tumor-infiltrating lymphocytes in intrahepatic cholangiocarcinoma: a population-based study. Scandinavian Journal of Gastroenterology 2022; 57(8): 965 doi: 10.1080/00365521.2022.2055972
|
16 |
Lian-Yuan Tao, Xiao-Dong He, Dian-Rong Xiu. Hepatitis B virus is associated with the clinical features and survival rate of patients with intrahepatic cholangiocarcinoma. Clinics and Research in Hepatology and Gastroenterology 2016; 40(6): 682 doi: 10.1016/j.clinre.2016.04.001
|
17 |
Jianbo Huang, Xiangyu Wang, Ying Zhu, Zheng Wang, Jianhua Li, Da Xu, Shenghao Wang, Tian‐En Li, Lu Lu. Specific prognostic factors in hepatitis B virus‐related and non‐hepatitis B virus–related intrahepatic cholangiocarcinoma after macroscopic curative resection. Journal of Surgical Oncology 2019; 119(1): 40 doi: 10.1002/jso.25303
|
18 |
Chul‐Soo Ahn, Shin Hwang, Young‐Joo Lee, Ki‐Hun Kim, Deok‐Bog Moon, Tae‐Yong Ha, Gi‐Won Song, Sung‐Gyu Lee. Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma. ANZ Journal of Surgery 2018; 88(3): 212 doi: 10.1111/ans.13753
|
19 |
Carlo Sposito, Michele Droz dit Busset, Matteo Virdis, Davide Citterio, Maria Flores, Marco Bongini, Monica Niger, Vincenzo Mazzaferro. The role of lymphadenectomy in the surgical treatment of intrahepatic cholangiocarcinoma: A review. European Journal of Surgical Oncology 2022; 48(1): 150 doi: 10.1016/j.ejso.2021.08.009
|
20 |
Sang‐Hyun Kang, Shin Hwang, Young‐Joo Lee, Ki‐Hun Kim, Chul‐Soo Ahn, Deok‐Bog Moon, Tae‐Yong Ha, Gi‐Won Song, Dong‐Hwan Jung, Sung‐Gyu Lee. Prognostic comparison of the 7th and 8th editions of the American Joint Committee on Cancer staging system for intrahepatic cholangiocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2018; 25(4): 240 doi: 10.1002/jhbp.543
|
21 |
Hisao Kano, Yutaka Midorikawa, Peipei Song, Hisashi Nakayama, Masamichi Moriguchi, Tokio Higaki, Shingo Tsuji, Tadatoshi Takayama. High C-reactive protein/albumin ratio associated with reduced survival due to advanced stage of intrahepatic cholangiocarcinoma. BioScience Trends 2020; 14(4): 304 doi: 10.5582/bst.2020.03167
|
22 |
Yun-Jau Chang, Yao-Jen Chang, Li-Ju Chen. Prognostic factors in patients with intrahepatic cholangiocarcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-70124-z
|
23 |
Kwang Min Kim, Ji Eun Na, Sang Goon Shim, Dong Hyun Sinn. Comparison of ICC patients with hepatitis B infection to those with no major risk factors for HCC. HPB 2021; 23(6): 945 doi: 10.1016/j.hpb.2020.10.011
|
24 |
Takamichi Ishii, Kentaro Iwaki, Akiyoshi Nakakura, Tomoaki Yoh, Yoichiro Uchida, Etsuro Hatano. Is routine lymph node dissection recommended for liver resection of intrahepatic cholangiocarcinoma? A systematic review and meta-analysis. HPB 2024; 26(6): 731 doi: 10.1016/j.hpb.2024.03.1163
|
25 |
Matthias Pinter, Michael Trauner, Markus Peck-Radosavljevic, Wolfgang Sieghart. Cancer and liver cirrhosis: implications on prognosis and management. ESMO Open 2016; 1(2): e000042 doi: 10.1136/esmoopen-2016-000042
|